Log in to save to my catalogue

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2...

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2870996879

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review

About this item

Full title

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Infection, 2024-02, Vol.52 (1), p.1-17

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Emerging SARS-CoV-2 variants have impacted the in vitro activity of sotrovimab, with variable fold changes in neutralization potency for the Omicron BA.2 sublineage and onward. The correlation between reduced in vitro activity and clinical efficacy outcomes is unknown. A systematic literature review (SLR) evaluated the effectiveness of s...

Alternative Titles

Full title

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2870996879

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2870996879

Other Identifiers

ISSN

0300-8126,1439-0973

E-ISSN

1439-0973

DOI

10.1007/s15010-023-02098-5

How to access this item